SAVING LIVES,
ONE BREATH AT A TIME

Your health story is written in your breath. We help clinicians read it early.

CancerWatch

CancerWatch hits all 4A’s to enable early detection

Simple Steps to Early Detection

Step 01

Step 02

Step 03

Step 04

/04

Accurate

90.8% specificity and 91.5% sensitivity

Accessible

The test can be taken anywhere by anyone

Affordable

More than 10x cheaper than any cancer screening package

Actionable

Risk-stratified VOC scores for clinicians to provide follow-up

Wear our custom mask and breathe for 10 minutes

Place the custom mask over your nose and mouth and breathe naturally for 10 minutes, allowing it to capture volatile organic compounds from your breath.

Seal and Ship it to Dognosis

Carefully seal the mask in the provided packaging and ship it to our diagnostic facility using the pre-labeled kit.

Advanced Analysis for VOC Health Signals

Once received, the mask undergoes analysis using our proprietary canine-AI system to detect volatile organic compounds (VOCs) in your breath. Our technology generates a VOC health score based on the patterns identified.

Results Delivered to Clinicians

A VOC risk stratification report is shared with your clinician, giving them the information they need to recommend appropriate next steps for your health. This simple, non-invasive process brings proactive health monitoring within reach, providing clinicians with vital risk information to guide timely follow-up and care.

Clinical Validation

years of peer-reviewed research

20 years of peer-reviewed research provides exemplary evidence that cancer-marker volatile organic compounds can be detected via canine olfaction with high accuracies.

91%

accuracy in detecting 7 types of cancers

Published in the Journal of Clinical Oncology, our largest study (1,502 participants across 6 hospitals) shows CancerWatch achieves 91% accuracy in detecting 7 types of cancers — with equally high sensitivity at early stages (I & II), when treatment options are greatest.

global conferences presented at

CancerWatch's clinical findings have been presented at ASCO 2025, EDCC 2025, IACR 2025, AACR FCS 2025, International Working Dogs Conference 2025, and Behaviour Kolkata 2025 — among the world's leading forums for cancer research and canine cognition.

Application & Use Cases

CancerWatch is currently being piloted as a general health monitoring tool, delivering VOC risk scores to clinicians. As part of our ongoing clinical research, we are validating a range of future applications -

Population-level health screening at scale

Multi-cancer early detection (MCED) to complement current methods

Catch any relapse at the earliest possible stage to accelerate treatment

The science of olfaction

Our Olfaction AI system leverages patented neuroAI technology to combine the gold-standard of olfactory detection with advanced machine learning to combine the best of biological and artificial intelligence.

Science

Explore More

FAQs

Everything you need know about Dognosis and the technology behind CancerWatch.

Product & Tech

No items found.

Subscribe to our newsletter

No items found.

Your health story is written in your breath. We help clinicians read it early.

CancerWatch

Simple Steps to Early Detection

Accurate

Accessible

Affordable

Actionable

Accurate

Accessible

Affordable

Actionable

Wear our custom mask and breathe for 10 minutes

Seal and Ship it to Dognosis

Advanced Analysis for VOC Health Signals

Results Delivered to Clinicians

Clinical Validation

years of peer-reviewed research

accuracy in detecting 7 types of cancers

global conferences presented at

Application & Use Cases

Population-level health screening at scale

Multi-cancer early detection (MCED) to complement current methods

Catch any relapse at the earliest possible stage to accelerate treatment

The science of olfaction

FAQs

Subscribe to our newsletter

Be first to know